APA (7th ed.) Citation

MA, S., OG, S., NH, S., N, F., & MA, K. (2020). LncRNA GAS5 and miR-137 Polymorphisms and Expression are Associated with Multiple Sclerosis Risk: Mechanistic Insights and Potential Clinical Impact. ACS chemical neuroscience, 11(11), 1651. https://doi.org/10.1021/acschemneuro.0c00150

Chicago Style (17th ed.) Citation

MA, Senousy, Shaker OG, Sayed NH, Fathy N, and Kortam MA. "LncRNA GAS5 and MiR-137 Polymorphisms and Expression Are Associated with Multiple Sclerosis Risk: Mechanistic Insights and Potential Clinical Impact." ACS Chemical Neuroscience 11, no. 11 (2020): 1651. https://doi.org/10.1021/acschemneuro.0c00150.

MLA (9th ed.) Citation

MA, Senousy, et al. "LncRNA GAS5 and MiR-137 Polymorphisms and Expression Are Associated with Multiple Sclerosis Risk: Mechanistic Insights and Potential Clinical Impact." ACS Chemical Neuroscience, vol. 11, no. 11, 2020, p. 1651, https://doi.org/10.1021/acschemneuro.0c00150.